Fig. 5From: Efficacy and safety of baricitinib in treatment of systemic lupus erythematosus: a systematic review and meta-analysisA forest plot displaying the prevalence of Systemic Lupus Erythematosus Disease Activity Index 2000 remission of arthritis or rash in the baricitinib group versus the placebo groupBack to article page